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ABSTRACT
Objective: Flavonoids from the crude seeds extract of Pongamia pinnata L., dried fruit powder of Morinda citrifolia L., bark of Mangifera indica L., and 
rhizome of Zingiber officinale Rosc. were screened for xanthine oxidase (XO) inhibition at different concentration. The inhibitory potential of quercetin 
and allopurinol were used for the determination of 50% inhibitory concentration (IC50) and Ki values.
Methods: Isolation of flavonoids from the plant extracts was processed by column chromatography and tested for XO inhibitory activity in the range 
of 6-800 µg/ml.
Results: The results demonstrated that optimized flavonoids extract of P. pinnata L. exhibited promising XO inhibition. P. pinnata L., M. indica L., and 
Z. officinale Rosc. had IC50 in the concentration of 8.74 mM, 1.09 mM, 5.4 mM and Ki 0.35 mM, 1.73 mM, 2.7 mM, respectively.
Conclusion: The study showed that plant species under investigation exhibited XO inhibition by optimized flavonoid extract. P. pinnata L. indicated 
promising XO inhibition compared to other plant extracts. Flavonoids can be used as a potent inhibitor of XO an alternative to allopurinol.
Keywords: Xanthine oxidase, Quercetin, Allopurinol, Pongamia pinnata, Oxidative stress.
INTRODUCTION
Traditional system of medicine comprises use of variety of bioactive 
compounds from the plants. The expeditions in search of medicinal 
values of plants are continuous process for therapeutic benefit. 
Plants sources are rich in pharmacologically active compounds such 
as phenolics, tannins, flavonoids, and lignin [1]. Such kind of active 
constituents distributed in different parts of the plants and posses 
properties of antimicrobial, antimutagenic, anticarcinogenic, anti-
inflammatory, vasodilatation, and enzyme inhibitory activity [2].
Pongamia pinnata L. is an angiosperm also known as Indian beach 
tree belongs to family Fabaceae. It is known to have anti-inflammatory, 
antiulcer, antidiarrheal, antibacterial, anticonvulsion, wound healing, 
hypoglycemic, etc. [3].
Morinda citrifolia L. also known as Indian mulberry or noni belongs 
to family Rubiaceae. Different parts of this plant used as antioxidant, 
anti-inflammatory, antihypertensive, antidiarrheal, antithrombotic, 
anticancerous, xanthine oxidase (XO) inhibitory and hypoglycemic, 
etc. [4,5].
Mangifera indica L. is well known as mango that belongs to family 
Anacardiaceae. The different parts of the plants used as remedial 
measure for infection, hypertension, insomnia, asthma, rheumatism, 
hemorrhage, and anemia [6,7].
Zingiber officinale Rosc. is called as ginger belongs to family 
Zingiberaceae. The rhizome contains zingiberene and gingerols. 
Precisely 6-gingerol is a constituent responsible for pungent taste. It 
is used as antipyretic, analgesic, hypotensive, antiplatelet aggregation, 
and thromboxane synthesis [8].
The aim of the study was to screen, in vitro efficacy of flavonoid 
components isolated from the seeds of P. pinnata L., dried fruit powder 
of M. citrifolia L., bark of M. indica L., and rhizome of Z. officinale Rosc. 
However, there is a need to determine XO enzyme inhibition to evaluate 
the protective effect on inflammation and oxidative stress.
Increased purine catabolism produces more reactive oxygen species 
as hydrogen peroxide and elevated uric acid level [9]. Furthermore, 
increased uric acid could be due to elevated XO activity. Hence, this has 
become subject of active research to screen for natural ingredients for 
therapeutics has become the need for the study. In vitro screening for 
XO inhibitory activity using vitamin C, vitamin E, flavonoid extracted 
from Indian conventional plants, along with allopurinol might be useful 
in extrapolating reduction of oxidative stress.
METHODS
Collection of plant material
Screening of XO inhibition was carried out using Indian conventional 
plants known to have medicinal property. They are P. pinnata L. (seeds), 
M. citrifolia L. (fruit), M. indica L. (bark), Z. officinale Rosc. (rhizome) 
were collected and authenticated from the Horticulture College, 
Tamaka, Kolar.
Preparation of plant extract
The methonolic extraction of P. pinnata L., M. citrifolia L., M. indica L., 
and Z. officinale Rosc. were carried out by following procedure. The 
plant materials were cleaned, air dried at room temperature in dark, 
ground to fine powder using pestle and mortar. Until further processing, 
the powder was stored in sterile amber colored bottle in dark at room 
temperature.
5 g of powder obtained was dissolved in 50 ml absolute methanol 
and subjected for filtration using whatman number 1 filter paper. The 
filtrate was concentrated in vacuum evaporator under reduced pressure 
and air dried. Thus obtained powder was stored in sterile bottles at 4°C 
until further use [10].
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Isolation and purification of flavonoids from the plant extracts by 
column chromatography
A glass column measuring 50×2 cm dimension developed using 
methanol with silica gel adsorbent on glass wool and allowed to settle by 
gravity flow. Column was allowed to equilibrate with suitable methanol 
as elution solvent. The even surface of the silica gel was protected by 
placing whatman number 1 filter paper disc. In this process, 1 g/ml 
of processed crude extract was applied for separation. All the eluted 
fractions were tested for flavonoid content, the active fractions were 
pooled and air dried under sterile conditions. The concentrated dried 
powder subjected for qualitative confirmation of flavonoids using 
dimethyl sulfoxide as a dissolving solvent and quercetin as an internal 
standard [11].
Qualitative detection of flavonoids
2 ml of above extract was treated with few drops of 20% sodium 
hydroxide which produced intense yellow color and on further addition 
of dilute hydrochloric acid became colorless confirming the presence of 
flavonoids [12].
XO inhibition assay
XO inhibition assay was done as per the method described by 
Bergmeyer. Test solution contained 1.9 ml of phosphate buffer, 0.5 ml 
of xanthine substrate, and 0.5 ml of inhibitor of interest. Contents 
were mixed by inversion and equilibrated to 25°C. To this equilibrated 
solution, added 0.1 ml of XO enzyme obtained from Sigma-Aldrich, 
USA. Blank contained 0.1 ml of distilled water in place of enzyme 
solution. Immediately mixed the contents and recorded the change 
in absorbance per minute for approximately 5 minutes at 290 nm in 
PerkinElmer Lambda 35 spectrophotometer. The maximum linear 
rate of absorbance change obtained per minute of test considered 
for calculation [13]. Concentration of inhibitors such as quercetin, 
allopurinol, vitamin C, vitamin E, and flavonoid extract of plants used in 
the range of 6-800 µg/ml were tested for XO inhibition.
5% methanol was used to solubilize vitamin E, quercetin, and flavonoids 
extract of plants except vitamin C and allopurinol which was dissolved 
in water. The distinct percentages of inhibition, 50% inhibitory 
concentration (IC50) and Ki were calculated.
RESULTS
Table 1 illustrating XO inhibition by pure chemical allopurinol, quercetin 
flavonoid, vitamin C and E and flavonoid components extracted from 
plants such as P. pinnata L., M. citrifolia L., M. indica L., and Z. officinale 
Rosc. The percentage of inhibition was calculated. In the similar 
way quercetin treated as internal standard flavonoid to compare the 
inhibitory activity of isolated flavonoids from the plants in the study. 
During the inhibition study, the results obtained using inhibitory 
components on XO activity was in the range of 6-800 µg/ml. It was 
evident that all the compounds exhibited ascending kind of inhibition 
from the concentration ranging from 50 to 800 µg/ml.
The percentage of inhibition of XO under assay condition by vitamin 
C and E clearly evinced that these vitamins had 50-60% of inhibition 
compared to allopurinol. The result showed that these vitamins have 
property of bringing minimal inhibition on enzyme activity irrespective 
of their concentration.
The results on percentage of inhibition of XO by isolated flavonoids 
of P. pinnata L. along with quercetin had similar inhibition property. 
However, M. citrifolia L., M. indica L., and Z. officinale Rosc. have less 
inhibitory effect on XO compared to P. pinnata. This observation 
suggested that flavonoid content of P. pinnata L. is almost similar 
to quercetin in action compared to others. Percentage of inhibition 
by quercetin on XO activity, when compared to allopurinol, showed 
approximately 40% less inhibition.
The percentage of inhibition at 800 µg/ml concentration for allopurinol 
was found 93.25%, quercetin 71.1%, vitamin C 50.7%, vitamin E 54%, 
P. pinnata L 69.1%, M. citrifolia L. 46.3%, M. indica L. 53.6%, Z. officinale 
Rosc. 51.6%. Results indicated other than allopurinol and quercetin, 
P. pinnata L. had maximum inhibitory activity.
The investigation on the efficacy of quercetin, vitamin E and vitamin C 
on comparison with optimized flavonoid extract from the above plants 
on XO inhibitory activity were calculated and expressed concentration 
that reduces half of enzyme activity (IC50) and inhibitory constant (Ki). 
Allopurinol a well-known competitive inhibitor of XO considered as 
positive control for comparison that showed IC50 value 0.4 mM and 
Ki 0.13 mM. Inhibitory effect of quercetin on XO showed IC50 value 
2.38 mM and Ki 0.37 mM. The vitamin C and E inhibition on XO in the 
concentration of IC50 10.6 mM, 1.19 mM and Ki 3.37 mM, 0.76 mM, 
respectively. P. pinnata L., M. indica L., and Z. officinale Rosc. showed XO 
inhibition in the concentration of IC50 8.74 mM,1.09 mM, 5.4 mM and Ki 
0.35 mM, 1.73 mM, 2.7 mM, respectively. However, M. citrifolia L. did not 
show effective XO inhibition.
DISCUSSION
Flavonoids are closely related polyphenolic compounds with flavone 
ring structure, ubiquitously distributed in various parts of the plants 
in the wide range. Flavonoids are classified into flavones, flavonols, 
flavonoids, chalcones, anthocyanins, tannins, and aurones. They 
are reported to have antioxidant, enzymes inhibition related to 
inflammation, cardioprotective and bactericidal property, etc. [14]. 
Flavonoids known to have potential inhibitory action on XO responsible 
for oxidative injury.
P. pinnata L., M. citrifolia L., M. indica L., and Z. officinale Rosc. subjected in the 
study for isolation of flavonoids compounds to test the inhibitory property 
on XO enzyme. P. pinnata L. seeds material reported to have inhibition on 
α-amylase and α-glucosidase activity [15]. Furthermore, inhibition of XO 
measured using commercially obtained pure flavonoids compounds and 
suggested the planar flavones (chrysin, luteolin, and flavones), flavonol 
(quercetin, myricetin, kaempferol, rhamnetin, tangeretin and rutin) were 
having strong inhibitory effect on XO activity (Nagao et al., 1999).
Information is limited on XO enzyme inhibition by P. pinnata L. seeds 
hence this study reported 74% of enzyme inhibition with reference to 
Table 1: Comparison of percentage of xanthine oxidase inhibition by allopurinol, pure and isolated flavonoids and vitamins at different 
concentrations
Compounds Percentage of inhibition at different concentration of inhibitor
6.25 µg/ml 12.5 µg/ml 25 µg/ml 50 µg/ml 100 µg/ml 200 µg/ml 400 µg/ml 800 µg/ml
Allopurinol 17.1±2.7 35.37±4.9 48.3±2.7 56.7±3.8 74.2±1.2 81.2±5.1 92.2±4.7 93.3±4.3
Quercetin 3.95±1.1 10.99±1.9 27.5±4.9 45.9±4.5 52.2±4.5 61.3±0.59 65.8±3.3 71.1±4.4
Vitamin C 8.94±1.3 18.3±2.5 25.1±2.7 26.8±4.6 31.8±1.8 46.4±0.68 48.8±3.9 50.7±2.8
Vitamin E 12.2±1.7 18.3±0.84 28.6±3.9 33.9±4.6 42.8±1.3 52.3±6.5 53.5±7.1 54±2.6
P. pinnata 3.3±1.8 6.7±0.5 27.5±4.4 45.9±3.4 52.2±1.0 62.9±2.1 65.9±2.6 69.1±1.1
M. citrifolia 8.9±0.9 15.6±72.8 23.9±1.7 33.9±4.1 39.5±1.8 42.9±2.8 45.1±0.9 46.3±1.1
M. indica 8.9±3.9 14.6±5.7 25.1±0.8 30.8±1.3 34.1±1.8 47.4±14.6 50.4±7.2 53.6±1.4
Z. officinale 7.3±0.59 12.2±0.8 21.02±1 27.7±2.6 37.6±3.7 44.5±2.8 49.7±4.2 51.6±0.6
P. pinnata: Pongamia pinnata L., M. citrifolia: Morinda citrifolia L., M. indica: Mangifera indica L., Z. officinale: Zingiber officinale Rosc.
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allopurinol and identified P. pinnata L. seeds flavonoids as the member 
of XO inhibitors from plant origin.
Palu et al. reported 64% of XO inhibition using a fine powder of fruit 
of M. citrifolia L. after processing [4]. Our research findings are similar 
with the study and able to obtain 50% of XO enzyme inhibition when 
compared to allopurinol. Mangiferin is a component of leaf known as 
xanthone C-glycoside of M. indica L. stands as a first report to state 
about inhibitory activity on XO [16]. Our study investigated to explore 
similar property in the bark and reports nearly 58% of inhibition with 
allopurinol used as standard inhibitor.
Gouticin a coded herbal formulation contains one of the ingredient is 
Z. officinale Rosc. which is reported to have potential inhibition on XO 
activity. The effective percentage of inhibition found to be similar with 
allopurinol an allopathic drug for gouty arthritis. In addition to this, 
gouticin also contains Apium graveolens, Colchicum autumnale, Tribulus 
terrestris, and Withania somnifera along with Z. officinale Rosc. [17]. Our 
study showed that nearly 55% of inhibition from the flavonoid extract 
obtained from the rhizome of Z. officinale compared with allopurinol.
In systemic meta-analysis of randomized control trials of various 
research findings reported that vitamin C supplementation as lowering 
serum uric acid level [18]. In an in vitro study on XO inhibition by 
L-ascorbic acid in trace amounts resulted decreased XO activity [19]. 
In our study, L-ascorbic acid reported to have 51% of XO inhibition at 
the concentration of 1.0 mg/ml when compared with allopurinol. The 
findings of our study are apparently similar by means of exhibiting 54% 
of inhibition at the concentration of 0.8 mg/ml [20].
In a randomized controlled animal study reported that the vitamin E 
inhibitory effect on XO related to gastric lesion prevention [21-23]. In 
cholestasis induced hepatocellular injury, supplementation of vitamin C 
and E as antioxidants exerted protective benefit through the mechanism 
of inhibition of XO and xanthine dehydrogenase reported [16]. In the 
same line of investigation our research findings supported this view by 
showing 58% of inhibition by vitamin E on pure form of XO.
Nevertheless several reports emphasized vitamin C and E inhibits 
XO activity. None of the report presented remarkable percentage of 
inhibition other than 52-55% range. In support of this WHO 2012 report 
described supplementation of vitamin C and E has no significance in 
reducing the risk of oxidative stress.
CONCLUSION
Flavonoids can also be used as natural inhibitor of XO. P. pinnata L. had 
maximum inhibitory activity. However, M. citrifolia L. did not show 
effective XO inhibition.
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